Here are 5 ASX biotechs expecting clinical trial results in the next few months!
Dimerix (ASX:DXB)
Dimerix is in the middle of a Phase III trial or its DMX-200 drug…
27
Skip to content
Skip to sidebar
Skip to footer
Stocks in Spotlight
View all →-
AI Stocks · Semiconductor stocks SanDisk (NASDAQ:SNDK) The Sell Case Behind a 3,300% AI Memory Rally May 21, 2026 -
Financials · Growth Stocks Powerhouse (ASX:PVL) Why the Re-Rate May Only Be Getting Started May 20, 2026
-
